Collectly

+0%

est. 2Y upside i

HealthcareSeries A

We help healthcare orgs collect more money faster

Rank

#2030

Sector

Healthcare Revenue Cycle Management (RCM) Software

Est. Liquidity

~2Y

Data Quality

Data: Low

Collectly has strong AI and integration tailwinds, but missing financial data and high incumbent risk make equality highly uncertain.

Last updated: July 19, 2026

Bull (20%)+66%

IPO window opens and AI category leadership sustains 6x multiple; projected $15.5M revenue yields $93M exit, net of dilution yields 66% upside.

Base (45%)+4%

Exit multiple converges to top of public comp range at 4x; exit value $62M, after dilution yields 4% upside.

Bear (35%)-43%

Multiple compresses to 2.5x, exit $38.75M, net of dilution -42.5%, but above $34.1M pref so common not zero.

Est. time to liquidity~2.0 years

Preference Stack Risk

high

Funding Intensity

34%

Total funding $34.1M represents 68% of estimated entry valuation, creating heavy preference overhang for common stock.

Dilution Risk

high

No funding since July 2023 and high cash burn likely necessitate a down round or at least 20% dilution within 2 years.

Secondary Liquidity

none

No secondary market activity reported; no liquidity options for employees.

Questions to Ask at the Interview

Strategic questions based on Collectly's data — designed to show you've done your homework.

1
“How does Collectly's competitive moat deepen against Epic and Waystar over the next 3 years?”
2
“What are the unit economics of your subscription model, specifically LTV/CAC and gross retention?”
3
“What is the expected timeline to liquidity via acquisition or IPO, and what milestones drive that?”

Our model estimates +0% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.